ESO/LinkedIn
Jul 21, 2026, 03:19
Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
European Stroke Organisation shared on LinkedIn:
”In this ESOC 2026 TV Studio session, anchors Manon Kappelhof and Gerrit M. Große are joined by Urs Fischer and Johanna Ospel to reflect on the latest evidence surrounding medium and distal vessel occlusions and their implications for the future of stroke treatment.
Key themes include:
- Why improved reperfusion rates have not consistently translated into better clinical outcomes
- Whether specific patient subgroups, particularly those with more severe neurological deficits, may still benefit from endovascular treatment
- How future studies can optimise patient selection, outcome measures and trial design to better evaluate treatment effects”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”
-
Sep 4, 2026, 21:41Chokri Ben Lamine: Fundamental HSCT Workshop for Hematology Fellows at HAAG 2026
-
Sep 4, 2026, 21:39Pierre Sabouret: A Good Surprise Our New Publication in Life Is Online